Cargando…

The role of different components of the immune system against Plasmodium falciparum malaria: Possible contribution towards malaria vaccine development

Plasmodium falciparum malaria still remains a major global public health challenge with over 220 million new cases and well over 400,000 deaths annually. Most of the deaths occur in sub-Saharan Africa which bears 90 % of the malaria cases. Such high P. falciparum malaria-related morbidity and mortal...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandala, Wilson L., Harawa, Visopo, Dzinjalamala, Fraction, Tembo, Dumizulu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier/North-Holland Biomedical Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655617/
https://www.ncbi.nlm.nih.gov/pubmed/34666102
http://dx.doi.org/10.1016/j.molbiopara.2021.111425
_version_ 1784612111100411904
author Mandala, Wilson L.
Harawa, Visopo
Dzinjalamala, Fraction
Tembo, Dumizulu
author_facet Mandala, Wilson L.
Harawa, Visopo
Dzinjalamala, Fraction
Tembo, Dumizulu
author_sort Mandala, Wilson L.
collection PubMed
description Plasmodium falciparum malaria still remains a major global public health challenge with over 220 million new cases and well over 400,000 deaths annually. Most of the deaths occur in sub-Saharan Africa which bears 90 % of the malaria cases. Such high P. falciparum malaria-related morbidity and mortality rates pose a huge burden on the health and economic wellbeing of the countries affected. Lately, substantial gains have been made in reducing malaria morbidity and mortality through intense malaria control initiatives such as use of effective antimalarials, intensive distribution and use of insecticide-treated nets (ITNs), and implementation of massive indoor residual spraying (IRS) campaigns. However, these gains are being threatened by widespread resistance of the parasite to antimalarials, and the vector to insecticides. Over the years the use of vaccines has proven to be the most reliable, cost-effective and efficient method for controlling the burden and spread of many infectious diseases, especially in resource poor settings with limited public health infrastructure. Nonetheless, this had not been the case with malaria until the most promising malaria vaccine candidate, RTS,S/AS01, was approved for pilot implementation programme in three African countries in 2015. This was regarded as the most important breakthrough in the fight against malaria. However, RTS,S/AS01 has been found to have some limitations, the main ones being low efficacy in certain age groups, poor immunogenicity and need for almost three boosters to attain a reasonable efficacy. Thus, the search for a more robust and effective malaria vaccine still continues and a better understanding of naturally acquired immune responses to the various stages, including the transmissible stages of the parasite, could be crucial in rational vaccine design. This review therefore compiles what is currently known about the basic biology of P. falciparum and the natural malaria immune response against malaria and progress made towards vaccine development.
format Online
Article
Text
id pubmed-8655617
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier/North-Holland Biomedical Press
record_format MEDLINE/PubMed
spelling pubmed-86556172021-12-22 The role of different components of the immune system against Plasmodium falciparum malaria: Possible contribution towards malaria vaccine development Mandala, Wilson L. Harawa, Visopo Dzinjalamala, Fraction Tembo, Dumizulu Mol Biochem Parasitol Article Plasmodium falciparum malaria still remains a major global public health challenge with over 220 million new cases and well over 400,000 deaths annually. Most of the deaths occur in sub-Saharan Africa which bears 90 % of the malaria cases. Such high P. falciparum malaria-related morbidity and mortality rates pose a huge burden on the health and economic wellbeing of the countries affected. Lately, substantial gains have been made in reducing malaria morbidity and mortality through intense malaria control initiatives such as use of effective antimalarials, intensive distribution and use of insecticide-treated nets (ITNs), and implementation of massive indoor residual spraying (IRS) campaigns. However, these gains are being threatened by widespread resistance of the parasite to antimalarials, and the vector to insecticides. Over the years the use of vaccines has proven to be the most reliable, cost-effective and efficient method for controlling the burden and spread of many infectious diseases, especially in resource poor settings with limited public health infrastructure. Nonetheless, this had not been the case with malaria until the most promising malaria vaccine candidate, RTS,S/AS01, was approved for pilot implementation programme in three African countries in 2015. This was regarded as the most important breakthrough in the fight against malaria. However, RTS,S/AS01 has been found to have some limitations, the main ones being low efficacy in certain age groups, poor immunogenicity and need for almost three boosters to attain a reasonable efficacy. Thus, the search for a more robust and effective malaria vaccine still continues and a better understanding of naturally acquired immune responses to the various stages, including the transmissible stages of the parasite, could be crucial in rational vaccine design. This review therefore compiles what is currently known about the basic biology of P. falciparum and the natural malaria immune response against malaria and progress made towards vaccine development. Elsevier/North-Holland Biomedical Press 2021-11 /pmc/articles/PMC8655617/ /pubmed/34666102 http://dx.doi.org/10.1016/j.molbiopara.2021.111425 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mandala, Wilson L.
Harawa, Visopo
Dzinjalamala, Fraction
Tembo, Dumizulu
The role of different components of the immune system against Plasmodium falciparum malaria: Possible contribution towards malaria vaccine development
title The role of different components of the immune system against Plasmodium falciparum malaria: Possible contribution towards malaria vaccine development
title_full The role of different components of the immune system against Plasmodium falciparum malaria: Possible contribution towards malaria vaccine development
title_fullStr The role of different components of the immune system against Plasmodium falciparum malaria: Possible contribution towards malaria vaccine development
title_full_unstemmed The role of different components of the immune system against Plasmodium falciparum malaria: Possible contribution towards malaria vaccine development
title_short The role of different components of the immune system against Plasmodium falciparum malaria: Possible contribution towards malaria vaccine development
title_sort role of different components of the immune system against plasmodium falciparum malaria: possible contribution towards malaria vaccine development
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655617/
https://www.ncbi.nlm.nih.gov/pubmed/34666102
http://dx.doi.org/10.1016/j.molbiopara.2021.111425
work_keys_str_mv AT mandalawilsonl theroleofdifferentcomponentsoftheimmunesystemagainstplasmodiumfalciparummalariapossiblecontributiontowardsmalariavaccinedevelopment
AT harawavisopo theroleofdifferentcomponentsoftheimmunesystemagainstplasmodiumfalciparummalariapossiblecontributiontowardsmalariavaccinedevelopment
AT dzinjalamalafraction theroleofdifferentcomponentsoftheimmunesystemagainstplasmodiumfalciparummalariapossiblecontributiontowardsmalariavaccinedevelopment
AT tembodumizulu theroleofdifferentcomponentsoftheimmunesystemagainstplasmodiumfalciparummalariapossiblecontributiontowardsmalariavaccinedevelopment
AT mandalawilsonl roleofdifferentcomponentsoftheimmunesystemagainstplasmodiumfalciparummalariapossiblecontributiontowardsmalariavaccinedevelopment
AT harawavisopo roleofdifferentcomponentsoftheimmunesystemagainstplasmodiumfalciparummalariapossiblecontributiontowardsmalariavaccinedevelopment
AT dzinjalamalafraction roleofdifferentcomponentsoftheimmunesystemagainstplasmodiumfalciparummalariapossiblecontributiontowardsmalariavaccinedevelopment
AT tembodumizulu roleofdifferentcomponentsoftheimmunesystemagainstplasmodiumfalciparummalariapossiblecontributiontowardsmalariavaccinedevelopment